Quest Diagnostics Quarterly Cash Flow Statement
NYSE: DGXHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
Quest Diagnostics free cash flow
In the quarter ended Jun 30, 2026, Quest Diagnostics generated $597.0 million of operating cash flow and spent $138.0 million on capital expenditures. That left free cash flow of $459.0 million, a free-cash-flow margin of 15.1% of revenue. Free cash flow was up 5.3% from the prior year's $436.0 million.
Quest Diagnostics returned $96.0 million to shareholders through dividends, equal to 21% of free cash flow. Free cash flow covered dividend payments 4.8 times.
Summary generated from market data by MetaCap's automated system. Methodology
Quest Diagnostics cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 334.00M | 264.00M | 256.00M | 259.00M | 296.00M | 235.00M | 236.00M | 237.00M | 240.00M | 208.00M | 205.00M | 237.00M |
| Net Income growth (YoY) | +12.84% | +12.34% | +8.47% | +9.28% | +23.33% | +12.98% | +15.12% | 0.00% | -3.61% | -4.15% | +76.72% | -14.13% |
| Depreciation & Amortization | 146.00M | 147.00M | 145.00M | 142.00M | 143.00M | 140.00M | 135.00M | 125.00M | 117.00M | 116.00M | 109.00M | 111.00M |
| Stock-Based Compensation | 23.00M | 20.00M | 25.00M | 20.00M | 21.00M | 22.00M | 27.00M | 19.00M | 20.00M | 22.00M | 19.00M | 18.00M |
| Change in Working Capital | 63.00M | -192.00M | 63.00M | 86.00M | 28.00M | -154.00M | 104.00M | -18.00M | 42.00M | -266.00M | 247.00M | -123.00M |
| Operating Cash Flow | 597.00M | 278.00M | 465.00M | 563.00M | 544.00M | 314.00M | 464.00M | 356.00M | 360.00M | 154.00M | 527.00M | 207.00M |
| Capital Expenditures | -138.00M | -114.00M | -158.00M | -144.00M | -108.00M | -117.00M | -123.00M | -106.00M | -92.00M | -104.00M | -72.00M | -105.00M |
| Investing Cash Flow | -134.00M | -152.00M | -191.00M | -201.00M | -124.00M | -115.00M | -502.00M | -1.63B | -200.00M | -213.00M | -114.00M | -107.00M |
| Dividends Paid | -96.00M | -88.00M | -90.00M | -89.00M | -90.00M | -84.00M | -84.00M | -84.00M | -84.00M | -79.00M | -80.00M | -80.00M |
| Share Repurchases | — | — | -300.00M | -150.00M | — | — | -151.00M | — | — | — | -275.00M | 0 |
| Debt Issued | 494.00M | 0 | 0 | 10.00M | 185.00M | 215.00M | 0 | 1.85B | 0 | 0 | 889.00M | 556.00M |
| Debt Repaid | -500.00M | -1.00M | -1.00M | -10.00M | -401.00M | -600.00M | -1.00M | -1.00M | -301.00M | 0 | -418.00M | -598.00M |
| Financing Cash Flow | -229.00M | -152.00M | -287.00M | -247.00M | -293.00M | -561.00M | -170.00M | 1.77B | -363.00M | -153.00M | 130.00M | -83.00M |
| Net Change in Cash | 233.00M | -27.00M | -12.00M | 113.00M | 131.00M | -361.00M | -215.00M | 493.00M | -203.00M | -212.00M | 543.00M | 17.00M |
| Free Cash Flow | 459.00M | 164.00M | 307.00M | 419.00M | 436.00M | 197.00M | 341.00M | 250.00M | 268.00M | 50.00M | 455.00M | 102.00M |
This table shows 12 quarterly periods of Quest Diagnostics's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow DGX's reporting calendar. What is a cash flow statement?